It was reported to be elevated in hepatocellular carcinoma, breast cancer, gastric cancer and melanoma, while decreased in nasopharyngeal carcinoma, prostate cancer and esophageal carcinoma, indicating the context-dependent role for ANXA1 in carcinogenesis 10-15. Here, ANXA1 is linked to breast carcinoma.